Codexis Announces New Employment Inducement Grants
09. März 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis to Participate in Cowen 43rd Annual Health Care Conference
27. Februar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will participate in both a panel discussion...
Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
23. Februar 2023 16:06 ET
|
Codexis, Inc.
Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications Cash Runway Through End of 2024 Funds Important...
Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency
23. Februar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, and Nestlé Health Science, a leader in the science of nutrition, today...
Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™
22. Februar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today highlights several key presentations from its gene therapy programs...
Codexis Announces New Employment Inducement Grants
15. Februar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the grant of an inducement award to the Company’s recently...
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23
09. Februar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth...
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
23. Januar 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer...
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
20. Dezember 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of...
Codexis Provides Update on Prioritized Corporate Strategy
29. November 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its...